Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

Figure 2

Kaplan-Meier plot showing the DFS (A) and OS (B) of TIMP-1 low and high anthracycline-treated patients. The median TIMP-1 concentration of the total patient group (12.5 ng/mg of total protein) was used as cut point (TIMP-1 low patients N = 46, TIMP-1 high patients N = 53). Cox univariate regression analysis; DFS: HR 1.52, 95% CI 0.88-2.63, P = 0.13; OS: HR 2.53, 95% CI 1.19-5.39, P = 0.02.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us